JP2002531412A - 脂質キャリヤー中にサイクロスポリンを含む医薬組成物 - Google Patents

脂質キャリヤー中にサイクロスポリンを含む医薬組成物

Info

Publication number
JP2002531412A
JP2002531412A JP2000584910A JP2000584910A JP2002531412A JP 2002531412 A JP2002531412 A JP 2002531412A JP 2000584910 A JP2000584910 A JP 2000584910A JP 2000584910 A JP2000584910 A JP 2000584910A JP 2002531412 A JP2002531412 A JP 2002531412A
Authority
JP
Japan
Prior art keywords
cyclosporin
lipid
pharmaceutical composition
polar
membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000584910A
Other languages
English (en)
Japanese (ja)
Inventor
ベングト・ヘーシュレフ
ペーテル・カウフマン
カール−グンナール・クルーン
Original Assignee
リポコーア・ホールディング・アクチエボラーグ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by リポコーア・ホールディング・アクチエボラーグ filed Critical リポコーア・ホールディング・アクチエボラーグ
Publication of JP2002531412A publication Critical patent/JP2002531412A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
JP2000584910A 1998-12-03 1999-12-03 脂質キャリヤー中にサイクロスポリンを含む医薬組成物 Pending JP2002531412A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9804192-4 1998-12-03
SE9804192A SE9804192D0 (sv) 1998-12-03 1998-12-03 New formulation
PCT/SE1999/002259 WO2000032219A1 (en) 1998-12-03 1999-12-03 A pharmaceutical composition comprising cyclosporin in a lipid carrier

Publications (1)

Publication Number Publication Date
JP2002531412A true JP2002531412A (ja) 2002-09-24

Family

ID=20413540

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000584910A Pending JP2002531412A (ja) 1998-12-03 1999-12-03 脂質キャリヤー中にサイクロスポリンを含む医薬組成物

Country Status (10)

Country Link
EP (1) EP1135152A1 (de)
JP (1) JP2002531412A (de)
AU (1) AU764413B2 (de)
CA (1) CA2352388A1 (de)
HU (1) HUP0105399A3 (de)
NO (1) NO20012736D0 (de)
NZ (1) NZ512194A (de)
PL (1) PL348062A1 (de)
SE (1) SE9804192D0 (de)
WO (1) WO2000032219A1 (de)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013146281A (ja) * 2004-03-17 2013-08-01 Freedom Health Llc 栄養補助食品
WO2014103742A1 (ja) * 2012-12-25 2014-07-03 ポーラ化成工業株式会社 逆ベシクル組成物及びその製造方法
JP2014141461A (ja) * 2012-12-25 2014-08-07 Pola Chem Ind Inc 逆ベシクル組成物
JP2014201522A (ja) * 2013-04-01 2014-10-27 ポーラ化成工業株式会社 逆ベシクル組成物の製造方法
JP2014201521A (ja) * 2013-04-01 2014-10-27 ポーラ化成工業株式会社 逆ベシクル組成物の製造方法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
SE0303135D0 (sv) * 2003-11-25 2003-11-25 Lipocore Holding Ab Controlled food effect composition
SE0401942D0 (sv) * 2004-07-28 2004-07-28 Lipopeptide Ab New antimicrobial peptide complexes
CA2607738A1 (en) * 2005-04-28 2006-11-02 Galenica Technology Ab Pharmaceutical dosage forms comprising a lipid phase
US20140044779A1 (en) * 2011-04-18 2014-02-13 Lipidor Ab Liquid Carrier for Oral Delivery of a Pharmacologically Active Agent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
US5529785A (en) * 1993-05-12 1996-06-25 Dietl; Hans Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing same
CN1091591C (zh) * 1994-02-04 2002-10-02 利珀克尔集团公司 亲脂载体制剂
IL129547A (en) * 1994-10-26 2001-01-11 Novartis Ag Pharmaceutical compositions comprising a macrolide and an acid
IT1289939B1 (it) * 1997-02-20 1998-10-19 Angelini Ricerche Spa Composizione farmaceutica acquosa comprendente un principio attivo altamente insolubile in acqua
US6063762A (en) * 1997-12-05 2000-05-16 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013146281A (ja) * 2004-03-17 2013-08-01 Freedom Health Llc 栄養補助食品
WO2014103742A1 (ja) * 2012-12-25 2014-07-03 ポーラ化成工業株式会社 逆ベシクル組成物及びその製造方法
JP2014141461A (ja) * 2012-12-25 2014-08-07 Pola Chem Ind Inc 逆ベシクル組成物
JP2014201522A (ja) * 2013-04-01 2014-10-27 ポーラ化成工業株式会社 逆ベシクル組成物の製造方法
JP2014201521A (ja) * 2013-04-01 2014-10-27 ポーラ化成工業株式会社 逆ベシクル組成物の製造方法

Also Published As

Publication number Publication date
WO2000032219A1 (en) 2000-06-08
NO20012736L (no) 2001-06-01
AU764413B2 (en) 2003-08-21
NO20012736D0 (no) 2001-06-01
SE9804192D0 (sv) 1998-12-03
HUP0105399A3 (en) 2005-06-28
NZ512194A (en) 2002-09-27
EP1135152A1 (de) 2001-09-26
PL348062A1 (en) 2002-05-06
HUP0105399A2 (en) 2002-06-29
CA2352388A1 (en) 2000-06-08
AU2016700A (en) 2000-06-19

Similar Documents

Publication Publication Date Title
US6355693B1 (en) Fractionated vegetable oil
KR100220546B1 (ko) 호지성 담체 제제
EP1011634B1 (de) Herstellung von arzneimitteln
CA2612128C (en) Methods and formulations for enhancing the absorption and decreasing the absorption variability of orally administered drugs, vitamins and nutrients
KR20000022353A (ko) 중간쇄 모노글리세리드를 함유한 소수성 조제
JPH09508413A (ja) 水中油エマルジョン
JPH10504532A (ja) ジアシルグリセロール、リン脂質、極性液体および生物活性物質を含有する脂質をベースとした組成物
JP2002531412A (ja) 脂質キャリヤー中にサイクロスポリンを含む医薬組成物
AU2003220643B2 (en) Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
US20130108689A1 (en) Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
EP0385445A2 (de) Verfahren zur Herstellung einer Suspension sowie das auf diese Weise hergestellte Mittel
JPH03165833A (ja) 新規懸濁化方法及びこの方法によって得られる組成物
US7053061B2 (en) Amphotercin B structured emulsion
KR100524700B1 (ko) 자가미세유화형 약물전달시스템을 이용한 고지혈증치료용약제 조성물
AU2001280084A1 (en) Amphotericin B structured emulsion
RU2740553C2 (ru) Способ получения липосомальной формы бетулина, обладающей гепатопротекторной активностью
RU2127124C1 (ru) Препараты липофильных носителей
MXPA99000275A (en) Hydrophobic preparations containing monoglycerides of average chain